Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab SC in Chinese Patients with RA
NCT03155347Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2017
- Primary completion
- Aug 2022
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Aug 2017; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03155347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03155347.